Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic ...
A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...
News-Medical.Net on MSN
Study reveals a therapeutic vulnerability in aggressive subtype of triple-negative breast cancer
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer ...
Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...
Morning Overview on MSN
New model hints Alzheimer’s could be rolled back, not just slowed
For more than 100 years, Alzheimer’s disease has been treated as a one‑way descent, a diagnosis that could be delayed at best ...
While Alzheimer’s was once thought as incurable and irreversible, new trials on mice in the US suggest that a cure may be on ...
Discover the transformative power of bond repair treatments for natural hair as we explore their benefits for damaged or ...
As of Wednesday, December 24, Repare Therapeutics Inc.’s RPTX share price has surged by 19.82%, which has investors questioning if this is right time to sell.
The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...
Study Finds on MSN
Major Alzheimer’s Breakthrough? Advanced-Stage Mice Fully Recover After Taking Experimental Compound
Scientists reversed advanced Alzheimer's in mice using a compound that restores cellular energy. The breakthrough challenges ...
Researchers created a new kind of cancer drug that can grab a mutant protein while also carrying a second hit against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback